Early-demographic dividend vs Guyana: Immunization, measles second dose
Early-demographic dividend
83.3%
in 2024
Guyana
97.0%
in 2024
Early-demographic dividend rank
17th
Guyana rank
19th
Immunization, measles second dose over time
- Early-demographic dividend
- Guyana
How they compare
Guyana currently reports 97.0% against 83.3% in Early-demographic dividend, a difference of 13.7%.
That makes Guyana's figure about 1.2 times Early-demographic dividend's.
Across all 24 years both countries report, Guyana has been ahead every year.
Early-demographic dividend ranks 17th and Guyana ranks 19th of 43 groups.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Early-demographic dividend | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.5% | 78.4% | 59.0% | Guyana |
| 2010s | 58.9% | 90.0% | 31.1% | Guyana |
| 2020s | 79.4% | 95.0% | 15.6% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Early-demographic dividend or Guyana?
- Guyana, at 97.0% against 83.3% in Early-demographic dividend as of 2024.
- What is the difference in immunization, measles second dose between Early-demographic dividend and Guyana?
- 13.7%, with Guyana ahead.
- How many years of comparable data are there for Early-demographic dividend and Guyana?
- 24 years are reported by both, from 2001 to 2024.
- How do Early-demographic dividend and Guyana rank globally for immunization, measles second dose?
- Early-demographic dividend ranks 17th and Guyana ranks 19th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.